+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • ID: 4851976
  • Report
  • March 2018
  • Region: Global
  • 201 pages
  • Transparency Market Research
1 of 2

Global Drug Delivery Systems Market: Overview

Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals and as a result it improves drug efficacy by controlling rate and time of release of drug. Drug delivery is a concept heavily integrated with dosage form and route of administration.

The global drug delivery systems market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on delivery system, application, route of administration, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Moreover, the section encompasses competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug delivery systems market.

Global Drug Delivery Systems Market: Key Segments

Based on delivery systems type the global drug delivery systems market is segmented into intrauterine implants, prodrug implants, polymeric drug delivery, and targeted drug delivery. The type of delivery system segment have been analyzed based on type of devices used to deliver drugs for different applications in various regions. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. According to application the global drug delivery systems market is segmented into infectious diseases, oncology, urology, diabetes, CNS, and others. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Drug Delivery Systems Market: Regional Outlook

Geographically, the global drug delivery systems market has been categorized into five major regions and the key countries in their respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, Rest of MEA). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players operating in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the drug delivery systems market include AstraZeneca plc., Bayer AG, Pfizer Inc., Novartis AG, Amgen Inc., Johnson and Johnson Services, Inc., Baxter International, Inc., Boston Scientific Corporation, and Becton, Dickinson & Company.

The global drug delivery systems market has been segmented as follows:

Drug Delivery Systems Market, by Type of Delivery System

  • Intrauterine Implants
  • Prodrug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Drug Delivery Systems Market, by Application

  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Drug Delivery Systems Market, by Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Ocular
  • Nasal
  • Topical

Drug Delivery Systems Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of MEA
Note: Product cover images may vary from those shown
2 of 2
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Drug Delivery Systems Market

Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution/Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Pipeline Analysis - Drug Therapy Products
4.4. Porter’s Five Force Analysis
4.5. Technological Advancement in Drug Delivery Products
4.6. Regulatory Scenario
4.7. Key Mergers and Acquisitions
4.8. Global Drug Delivery Systems Market Analysis and Forecasts, 2015-2025
4.8.1. Market Revenue Projection (US$ Mn)
4.8.2. Market Outlook

Chapter 5. Global Drug Delivery Systems Market Analysis and Forecasts, by Type of Delivery System
5.1. Key Findings/Developments
5.2. Introduction & Definition
5.3. Market Value Forecast by Delivery Systems, 2016-2025
5.3.1. Intrauterine Implants
5.3.2. Prodrug Implants
5.3.3. Polymeric Drug Delivery
5.3.4. Targeted Drug Delivery
5.4. Market Attractiveness by Delivery Systems

Chapter 6. Global Drug Delivery Systems Market Analysis and Forecasts, by Application
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast by Application, 2016-2025
6.3.1. Infectious Diseases
6.3.2. Oncology
6.3.3. Ophthalmology
6.3.4. Urology
6.3.5. Diabetes
6.3.6. CNS
6.3.7. Others
6.4. Market Attractiveness by Application

Chapter 7. Global Drug Delivery Systems Market Analysis and Forecasts, by Route of Administration
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast by Route of Administration, 2016-2025
7.3.1. Oral
7.3.2. Injectable
7.3.3. Inhalation
7.3.4. Transdermal
7.3.5. Ocular
7.3.6. Nasal
7.3.7. Topical
7.4. Market Attractiveness by Route of Administration

Chapter 8. Global Drug Delivery Systems Market Analysis and Forecasts, by Geography/Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness by Region

Chapter 9. North America Drug Delivery Systems Market Analysis and Forecast
9.1. Market Value Forecast by Country, 2017-2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast by Type of Delivery System, 2016-2025
9.3. Market Value Forecast by Application, 2016-2025
9.4. Market Value Forecast by Route of Administration, 2016-2025
9.5. Market Attractiveness Analysis
9.5.1. by Country
9.5.2. by Type of Delivery System
9.5.3. by Application
9.5.4. by Route of Administration

Chapter 10. Europe Drug Delivery Systems Market Analysis and Forecast
10.1. Market Value Forecast by Country, 2017-2025
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast by Type of Delivery System, 2016-2025
10.3. Market Value Forecast by Application, 2016-2025
10.4. Market Value Forecast by Route of Administration, 2016-2025
10.5. Market Attractiveness Analysis
10.5.1. by Country
10.5.2. by Type of Delivery System
10.5.3. by Application
10.5.4. by Route of Administration

Chapter 11. Asia Pacific Drug Delivery Systems Market Analysis and Forecast
11.1. Market Value Forecast by Country, 2017-2025
11.1.1. China
11.1.2. Japan
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast by Type of Delivery System, 2016-2025
11.3. Market Value Forecast by Application, 2016-2025
11.4. Market Value Forecast by Route of Administration, 2016-2025
11.5. Market Attractiveness Analysis
11.5.1. by Country
11.5.2. by Delivery Systems
11.5.3. by Application
11.5.4. by Route of Administration

Chapter 12. Latin America Drug Delivery Systems Market Analysis and Forecast
12.1. Market Value Forecast by Country, 2017-2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of LATAM
12.2. Market Value Forecast by Type of Delivery System, 2016-2025
12.3. Market Value Forecast by Application, 2016-2025
12.4. Market Value Forecast by Route of Administration, 2016-2025
12.5. Market Attractiveness Analysis
12.5.1. by Country
12.5.2. by Delivery Systems
12.5.3. by Application
12.5.4. by Route of Administration

Chapter 13. Middle East and Africa Drug Delivery Systems Market Analysis and Forecast
13.1. Market Value Forecast by Country, 2017-2025
13.1.1. GCC Countries
13.1.2. South Africa
13.1.3. Israel
13.1.4. Rest of MEA
13.2. Market Value Forecast by Type of Delivery System, 2016-2025
13.3. Market Value Forecast by Application, 2016-2025
13.4. Market Value Forecast by Route of Administration, 2016-2025
13.5. Market Attractiveness Analysis
13.5.1. by Country
13.5.2. by Delivery Systems
13.5.3. by Application
13.5.4. by Route of Administration

Chapter 14. Competition Landscape
14.1. Competition Matrix
14.1.1. Novartis AG
14.1.2. Amgen Inc.
14.1.3. F. Hoffmann-La Roche Ltd.
14.1.4. Pfizer Inc.
14.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
14.2.1. Novartis AG (HQ, Business Segments, Employee Strength)
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Amgen Inc. (HQ, Business Segments, Employee Strength)
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. F.Hoffmann-La Roche Ltd. (HQ, Business Segments, Employee Strength)
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Pfizer Inc. (HQ, Business Segments, Employee Strength)
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Johnson & Johnson Services, ltd. (HQ, Business Segments, Employee Strength)
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. Becton, Dickinson and Company (HQ, Business Segments, Employee Strength)
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. AstraZeneca plc (HQ, Business Segments, Employee Strength)
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. Baxter International, Inc. (HQ, Business Segments, Employee Strength)
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. Bayer AG (HQ, Business Segments, Employee Strength)
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
14.2.10.1. Company Details
14.2.10.2. Company Description
14.2.10.3. Business Overview
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll